Cargando…
Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial
CONTEXT: Pretreatment with α-adrenergic receptor blockers is recommended to prevent hemodynamic instability during resection of a pheochromocytoma or sympathetic paraganglioma (PPGL). OBJECTIVE: To determine which type of α-adrenergic receptor blocker provides the best efficacy. DESIGN: Randomized c...
Autores principales: | Buitenwerf, Edward, Osinga, Thamara E, Timmers, Henri J L M, Lenders, Jacques W M, Feelders, Richard A, Eekhoff, Elisabeth M W, Haak, Harm R, Corssmit, Eleonora P M, Bisschop, Peter H L T, Valk, Gerlof D, Veldman, Ronald Groote, Dullaart, Robin P F, Links, Thera P, Voogd, Magiel F, Wietasch, Götz J K G, Kerstens, Michiel N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261201/ https://www.ncbi.nlm.nih.gov/pubmed/31714582 http://dx.doi.org/10.1210/clinem/dgz188 |
Ejemplares similares
-
Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients
por: Berends, Annika M. A., et al.
Publicado: (2022) -
Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2016) -
Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality
por: Ettaieb, Madeleine H. T., et al.
Publicado: (2020) -
Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019) -
Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry
por: Steenaard, Rebecca V., et al.
Publicado: (2022)